The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of neoadjuvant treatment with gemcitabine with nab-paclitaxel on SPARC and Ki-67 in patients with resectable pancreatic adenocarcinoma.
 
Sarunas Sliesoraitis
No Relationships to Disclose
 
Amy L. Collinsworth
No Relationships to Disclose
 
Jose Gilberto Trevino
No Relationships to Disclose
 
Robert Zlotecki
No Relationships to Disclose
 
Xiaomin Lu
No Relationships to Disclose
 
Judith L. Lightsey
No Relationships to Disclose
 
Carmen Joseph Allegra
No Relationships to Disclose
 
Ahmad Alkhasawneh
No Relationships to Disclose
 
Long H. Dang
No Relationships to Disclose
 
Karen Colleen Daily
No Relationships to Disclose
 
Kevin Behrns
No Relationships to Disclose
 
Chen Liu
No Relationships to Disclose
 
Steven J. Hughes
No Relationships to Disclose
 
Alison Marguerite Ivey
No Relationships to Disclose
 
Shailendra Chauhan
No Relationships to Disclose
 
Neelam Vijay Desai
No Relationships to Disclose
 
Thomas J. George
Consulting or Advisory Role - Bayer/Onyx; Regeneron
Research Funding - Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst)